SCHEMBL6252203

SCHEMBL6252203

COc1cc2c(cc1OC)CC(C=O)CC2

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 2/20 0.46
ALDH1A1 P00352 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
ACHE P22303 1/20 0.41
MAOB P27338 2/20 0.40
RAD52 P43351 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CHRNA7 P36544 1/20 0.40
MAOA P21397 1/20 0.40
SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27390763 0.89 ALDH1A1 (0.49) PDE4DALDH1A1CYP2D6CYP2C9ALOX15
SCHEMBL13626343 0.79 ATM (0.47) ACHE
SCHEMBL19281913 0.78 DRD2 (0.62) ALDH1A1MAPK1CA1CA2CYP3A4
SCHEMBL12924515 0.76 CYP3A4 (0.46) ALDH1A1CYP2D6CYP2C9ALOX15MAPK1
SCHEMBL28949968 0.75 CA1 (0.51) PDE4DCA1CA2RAD52CHRNA7
SCHEMBL8765937 0.74 DRD2 (0.62) ALDH1A1MAPTKDM4E
SCHEMBL7339771 0.74 DRD2 (0.62) ALDH1A1MAPTKDM4E
SCHEMBL7781955 0.74 DRD2 (0.62) ALDH1A1MAPTKDM4E
SCHEMBL27784442 0.73 MAOA (0.50) PDE4DALDH1A1CA1CA2MAOA
Hydrochloric Acid SCHEMBL9781826 0.73 DRD2 (0.60) ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1568368-A1 Pharmaceutical combination comprising a CDK inhibitor and a VEGF receptor inhibitor SCHERING AKTIENGESELLSCHAFT (DE) 2005-08-31 EP claimed
CN-102424670-A Method for synthesizing 3- (3-chloropropyl) -1,3,4, 5-tetrahydro-7, 8-dimethoxy-2H-3-benzazepin-2-ketone JIANGSU ALPHA PHARMACEUTICAL CO LTD 2012-04-25 CN disclosed
CN-100352806-C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists HOFFMANN LA ROCHE (CH) 2007-12-05 CN disclosed
EP-1568368-A1 Pharmaceutical combination comprising a CDK inhibitor and a VEGF receptor inhibitor SCHERING AKTIENGESELLSCHAFT (DE) 2005-08-31 EP disclosed
CN-1599722-A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists HOFFMANN LA ROCHE (CH) 2005-03-23 CN disclosed